LQ3 Pharmaceuticals
Morrisville, US · Founded 2013
Founders & leadership
TA
Tim AlburyExecutive
SG
Shawn GliddenExecutive
KC
Kyle ChenetExecutive
Board
SR
Seth RudnickBoard director
SB
Stephen BlochBoard director
NF
Neal FowlerBoard director
Reported raises · per SEC filings
Form D private placements$2.4M disclosed across 1 round · 2014
▶$2.4MraisedDec 2014 · 4 investors · PharmaceuticalsRule 506(b)
▶$2.4MraisedDec 2014 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Neal FowlerDirector
- Seth RudnickDirector
- Stephen BlochDirector
- Tim AlburyExecutive Officer
- Shawn GliddenExecutive Officer
- Kyle ChenetExecutive Officer, Director, Promoter
- Offering amount
- $10M
- Amount sold
- $2.4M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has LQ3 Pharmaceuticals raised?
- LQ3 Pharmaceuticals has disclosed $2.4M raised across 1 round.
- Where is LQ3 Pharmaceuticals headquartered?
- LQ3 Pharmaceuticals is headquartered in Morrisville, US.